PRME - NASDAQ
Prime Medicine, Inc.
$3.14
-2.2%Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.
At a Glance
Live SnapshotNo Dividend Yield Data
PRME has not reported any dividend yield values in the available annual periods.
No Dividend Payout Ratio Data
PRME has not reported any dividend payout ratio values in the available annual periods.
No Net Dividends Paid Data
PRME has not reported any net dividends paid values in the available annual periods.
Prime Medicine, Inc. Dividend History
PRME Dividend Payment History
Total Payments
15
Latest Dividend
$0.8000
Annual Amount
$1.4460
Frequency
Quarterly
| Declaration | Ex-Date | Payment Date | Dividend | Adjusted | Frequency | Growth |
|---|---|---|---|---|---|---|
Sep 9, 2019 | Sep 10, 2019 | Sep 12, 2019 | $0.8000 | $0.8000 | Quarterly | +300.00% |
Jan 21, 2019 | Jun 14, 2019 | Jun 28, 2019 | $0.2000 | $0.2000 | Quarterly | -6.10% |
Jan 11, 2018 | Dec 18, 2018 | Dec 31, 2018 | $0.2130 | $0.2130 | Quarterly | -8.58% |
Jan 11, 2018 | Sep 14, 2018 | Sep 28, 2018 | $0.2330 | $0.2330 | Quarterly | +59.59% |
Jan 11, 2018 | Jun 21, 2018 | Jun 29, 2018 | $0.1460 | $0.1460 | Quarterly | +2333.33% |
Jan 11, 2018 | Mar 22, 2018 | Mar 29, 2018 | $0.0060 | $0.0060 | Quarterly | -99.30% |
Dec 20, 2017 | Dec 21, 2017 | Dec 29, 2017 | $0.8610 | $0.8610 | Quarterly | +1204.55% |
Sep 20, 2017 | Sep 21, 2017 | Sep 29, 2017 | $0.0660 | $0.0660 | Quarterly | -41.07% |
N/A | Jun 22, 2017 | Jun 30, 2017 | $0.1120 | $0.1120 | Quarterly | +273.33% |
N/A | Mar 23, 2017 | Mar 31, 2017 | $0.0300 | $0.0300 | Quarterly | -95.87% |
N/A | Dec 21, 2016 | Dec 30, 2016 | $0.7270 | $0.7270 | Quarterly | +354.38% |
N/A | Sep 21, 2016 | Sep 30, 2016 | $0.1650 | $0.1600 | Quarterly | -3.61% |
N/A | Jun 22, 2016 | Jun 30, 2016 | $0.1660 | $0.1660 | Quarterly | +730.00% |
Mar 23, 2016 | Mar 23, 2016 | Mar 31, 2016 | $0.0200 | $0.0200 | Quarterly | -77.78% |
Dec 23, 2015 | Dec 23, 2015 | Dec 31, 2015 | $0.0900 | $0.0900 | Quarterly | - |
Prime Medicine, Inc. Payout Ratio Analysis
Dividend Sustainability Analysis
Payout Ratio
Conservative payout with excellent safety margin. Company retains significant earnings for growth, acquisitions, or building cash reserves. Dividend is highly sustainable.
FCF Payout Ratio
Negative free cash flow while paying dividends is a major red flag. Company burning cash and cannot sustain dividend without external financing.
Sustainability
Dividend appears unsustainable based on current metrics. High probability of reduction or elimination. Proceed with caution.
Related Guides
Continue your PRME research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.